Peter Niraj Nirmalraj

This study uses nanospectroscopy to analyze how anti-amyloid antibodies affect Aβ-42 protein aggregates, finding differences in oligomer reduction and fibril formation between aducanumab and lecanemab.

This study investigates how Levodopa affects the structure of -Synuclein and A{beta}-42 protein fibrils at the nanoscale using atomic force microscopy and molecular dynamics simulations.